12,000 diabetes patients to test remote monitoring system

NCT ID NCT07617519

First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study will look at whether a remote patient monitoring system, called Steno Detektor, helps people with diabetes control their blood sugar. About 12,000 patients will be monitored as part of their regular care. Researchers will compare blood sugar levels and hospital visits before and after the system was introduced.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Remote patient monitoring system (Steno Detektor)
What this could lead to
If successful, this could show that remote monitoring helps people with diabetes manage their blood sugar levels as well as or better than standard care, potentially reducing hospital visits.
What could go wrong
This is an observational study, not a randomized trial, so results may be influenced by other factors. The system is already in use, so it may not show a clear benefit over existing care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Steno Diabetes Center Copenhagen

    RECRUITING

    Herlev, 2730, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.